84612-399-01 |
84612-399 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Optum Health Solutions (Ireland) Limited |
ADALIMUMAB |
20 mg/.2mL |
1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE |
72511-479-02 |
72511-479 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20241108 |
N/A |
BLA |
BLA761024 |
Amgen USA Inc. |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
55513-400-01 |
55513-400 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.8mL |
1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
55513-400-02 |
55513-400 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.8mL |
2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
55513-400-91 |
55513-400 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.8mL |
1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
55513-479-01 |
55513-479 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
55513-479-02 |
55513-479 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
84612-479-01 |
84612-479 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Optum Health Solutions (Ireland) Limited |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
84612-479-02 |
84612-479 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Optum Health Solutions (Ireland) Limited |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
50090-6428-0 |
50090-6428 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230410 |
N/A |
BLA |
BLA761024 |
A-S Medication Solutions |
ADALIMUMAB |
40 mg/.8mL |
2 SYRINGE in 1 CARTON (50090-6428-0) / .8 mL in 1 SYRINGE |
72511-481-02 |
72511-481 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20241015 |
N/A |
BLA |
BLA761024 |
Amgen USA Inc. |
ADALIMUMAB |
80 mg/.8mL |
2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
55513-410-01 |
55513-410 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.8mL |
1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
55513-410-02 |
55513-410 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
40 mg/.8mL |
2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
55513-480-01 |
55513-480 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
80 mg/.8mL |
1 SYRINGE in 1 CARTON (55513-480-01) / .8 mL in 1 SYRINGE |
55513-480-02 |
55513-480 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
80 mg/.8mL |
2 SYRINGE in 1 CARTON (55513-480-02) / .8 mL in 1 SYRINGE |
84612-482-01 |
84612-482 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Optum Health Solutions (Ireland) Limited |
ADALIMUMAB |
40 mg/.4mL |
1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
84612-482-02 |
84612-482 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Optum Health Solutions (Ireland) Limited |
ADALIMUMAB |
40 mg/.4mL |
2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
72511-400-01 |
72511-400 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen USA Inc. |
ADALIMUMAB |
40 mg/.8mL |
1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
72511-400-02 |
72511-400 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230131 |
N/A |
BLA |
BLA761024 |
Amgen USA Inc. |
ADALIMUMAB |
40 mg/.8mL |
2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
55513-399-01 |
55513-399 |
HUMAN PRESCRIPTION DRUG |
AMJEVITA |
adalimumab-atto |
INJECTION |
SUBCUTANEOUS |
20230814 |
N/A |
BLA |
BLA761024 |
Amgen Inc |
ADALIMUMAB |
20 mg/.2mL |
1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE |